Evidence map›Paper›PMID 32881384›Full record

ArticleChemPlusChem2020

Advances in Antiviral Material Development.

Lili Liang, Ashiq Ahamed, Liya Ge, Xiaoxu Fu, Grzegorz Lisak

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ChemPlusChem, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Cu-bearing high-entropy alloys with excellent antiviral properties.Journal of materials science & technology · 2021
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lili LiangNanyang Technological University, School of Civil and Environmental Engineering, SINGAPORE.
Ashiq AhamedNanyang Technological University, School of Civil and Environmental Engineering, SINGAPORE.
Liya GeNanyang Technological University, School of Civil and Environmental Engineering, SINGAPORE.
Xiaoxu FuNanyang Technological University, School of Civil and Environmental Engineering, SINGAPORE.
Grzegorz LisakNanyang Technological University, School of Civil and Environmental Engineering, 50 nanyang Avenue, 639804, Singapore, SINGAPORE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rise in human pandemics demands prudent approaches in antiviral material development for disease prevention and treatment via effective protective equipment and therapeutic strategy. However, the current state of the antiviral materials research is predominantly aligned towards drug development and its related areas, catering to the field of pharmaceutical technology. This review distinguishes the research advances in terms of innovative materials exhibiting antiviral activities that take advantage of fast-developing nanotechnology and biopolymer technology. Essential concepts of antiviral principles and underlying mechanisms are illustrated, followed with detailed descriptions of novel antiviral materials including inorganic nanomaterials, organic nanomaterials and biopolymers. The biomedical applications of the antiviral materials are also elaborated based on the specific categorization. Challenges and future prospects are discussed to facilitate the research and development of protective solutions and curative treatments.

Indexed as

antiviral materials * biopolymers * drug delivery * nanoparticles * viruses

Identifiers

PMID32881384
PMCPMC7461489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.